GATA2 and pulmonary hypertension: Ventilation-diffusion defects can be demonstrated in about two-thirds of GATA2-deficient patients while pulmonary hypertension (PAH) and pulmonary alveolar proteinosis (PAP) are some of the rare manifestations occurring in <20% in one series 53.